G Mechkov

450 total citations
13 papers, 354 citations indexed

About

G Mechkov is a scholar working on Pathology and Forensic Medicine, Parasitology and Epidemiology. According to data from OpenAlex, G Mechkov has authored 13 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 6 papers in Parasitology and 4 papers in Epidemiology. Recurrent topics in G Mechkov's work include Parasitic infections in humans and animals (8 papers), Parasitic Infections and Diagnostics (6 papers) and Congenital Anomalies and Fetal Surgery (3 papers). G Mechkov is often cited by papers focused on Parasitic infections in humans and animals (8 papers), Parasitic Infections and Diagnostics (6 papers) and Congenital Anomalies and Fetal Surgery (3 papers). G Mechkov collaborates with scholars based in Bulgaria, United States and Austria. G Mechkov's co-authors include K. Vutova, T Todorov, Krasimir Kolev, Zahary Krastev, Elsa Mondou, Franck Rousseau, A. Lynn Snow, Seng Gee Lim, Iskren Kotzev and J. Sorbel and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Hepatology and Inflammatory Bowel Diseases.

In The Last Decade

G Mechkov

13 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Mechkov Bulgaria 8 257 173 116 85 85 13 354
Isabelle Beurton France 8 363 1.4× 223 1.3× 284 2.4× 56 0.7× 76 0.9× 12 434
Joel Martínez-Ocaña Mexico 11 267 1.0× 151 0.9× 252 2.2× 61 0.7× 63 0.7× 18 383
Tommaso Manciulli Italy 10 158 0.6× 157 0.9× 75 0.6× 21 0.2× 98 1.2× 38 289
Angélica Melo A Chile 12 112 0.4× 209 1.2× 48 0.4× 32 0.4× 24 0.3× 37 357
Sniedze Laivacuma Latvia 6 48 0.2× 46 0.3× 34 0.3× 31 0.4× 44 0.5× 11 201
E. A. Coltorti Switzerland 17 569 2.2× 268 1.5× 436 3.8× 115 1.4× 77 0.9× 25 655
Janet A. Fried United States 8 369 1.4× 236 1.4× 258 2.2× 111 1.3× 40 0.5× 10 446
Sophia M. Cohen United States 8 50 0.2× 33 0.2× 34 0.3× 24 0.3× 52 0.6× 12 201
S Notargiacomo Italy 9 402 1.6× 235 1.4× 320 2.8× 45 0.5× 118 1.4× 11 441
W Hassine 4 642 2.5× 579 3.3× 126 1.1× 178 2.1× 214 2.5× 7 682

Countries citing papers authored by G Mechkov

Since Specialization
Citations

This map shows the geographic impact of G Mechkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Mechkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Mechkov more than expected).

Fields of papers citing papers by G Mechkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Mechkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Mechkov. The network helps show where G Mechkov may publish in the future.

Co-authorship network of co-authors of G Mechkov

This figure shows the co-authorship network connecting the top 25 collaborators of G Mechkov. A scholar is included among the top collaborators of G Mechkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Mechkov. G Mechkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Baumgart, Daniel C., Stephan R. Targan, Axel Dignaß, et al.. (2009). Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis†. Inflammatory Bowel Diseases. 16(4). 620–629. 38 indexed citations
2.
Lim, Seng Gee, Zahary Krastev, G Mechkov, et al.. (2006). Randomized, Double-Blind Study of Emtricitabine (FTC) plus Clevudine versus FTC Alone in Treatment of Chronic Hepatitis B. Antimicrobial Agents and Chemotherapy. 50(5). 1642–1648. 36 indexed citations
3.
Тодоров, Тодор, et al.. (2003). Double aldehyde stabilisation of erythrocytes in the indirect hemagglutination for echinococcosis. Parasitology International. 52(3). 203–207. 1 indexed citations
5.
Vutova, K., et al.. (1999). Effect of mebendazole on human cystic echinococcosis: the role of dosage and treatment duration. Annals of Tropical Medicine and Parasitology. 93(4). 357–365. 22 indexed citations
6.
Todorov, T, et al.. (1992). Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole. Annals of Tropical Medicine and Parasitology. 86(1). 59–66. 65 indexed citations
7.
Todorov, T, et al.. (1992). Experience in the chemotherapy of severe, inoperable echinococcosis in man. Infection. 20(1). 19–24. 20 indexed citations
8.
Todorov, T, et al.. (1992). Factors influencing the response to chemotherapy in human cystic echinococcosis.. PubMed. 70(3). 347–58. 57 indexed citations
9.
Georgiev, P & G Mechkov. (1991). [The differentiation of cirrhotic from malignant ascites by ultrasonic tomography of the gallbladder].. PubMed. 30(2). 94–6. 1 indexed citations
10.
Todorov, T, et al.. (1990). Evaluation of response to chemotherapy of human cystic echinococcosis. British Journal of Radiology. 63(751). 523–531. 77 indexed citations
11.
Тодоров, Тодор, et al.. (1990). Chemotherapy of liver and pulmonary hydatid disease with mebendazole.. 5(1). 5–19. 3 indexed citations
12.
Todorov, T, et al.. (1988). Albendazole treatment of human cystic echinococcosis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 82(3). 453–459. 29 indexed citations
13.
Mechkov, G, et al.. (1985). [Diagnostic value of ultrasonic tomography in thyroid tumors].. PubMed. 24(6). 54–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026